New drug application for treatment of thyroid cancer

CStone Pharmaceuticals today announced that the National Medical Products Administration (NMPA) of China has approved the supplemental new drug

Related Keywords

China ,Taiwan ,United States ,Tianjin ,Hong Kong ,Ming Gao ,Henan ,Macau ,Chinese ,American ,Jason Yang ,Frank Jiang ,Tianjin Union Medical Center ,Cstone Pharmaceuticals ,Friendly ,Meeting Of The American Thyroid Association ,National Medical Products Administration ,Blueprint Medicines ,Greater China ,Mainland China ,Principal Investigator ,Chief Medical Officer ,Annual Meeting ,American Thyroid Association ,